Inotek Pharmaceuticals CEO Gaurav Shah receives $6.4M in 2018
Inotek Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 30, 2019
Inotek Pharmaceuticals reported fiscal year 2018 executive compensation information on April 30, 2019.
In 2018, four executives at Inotek Pharmaceuticals received on average a compensation package of $3.4M, a 294% increase compared to previous year.
Average pay of disclosed executives at Inotek Pharmaceuticals
Gaurav D. Shah, Chief Executive Officer, received $6.4M in total. 89% of Shah's compensation, or $5.7M, was in option awards. Shah also received $301K in bonus, $414K in salary, as well as $9.9K in other compensation.
Kinnari Patel, Chief Operating Officer, received a compensation package of $3M. 81% of the compensation package, or $2.4M, was in option awards.
David P. Southwell, Chief Executive Officer, earned $2.7M in 2018, a 116% increase compared to previous year.
Jonathan Schwartz, Chief Medical Officer, received $1.4M in 2018.
Related executives
You may also like
Source: SEC filing on April 30, 2019.